Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2021	Nov. 30, 2020	Nov. 30, 2021	Nov. 30, 2020
Sales	$ 324,240	$ 0	$ 324,240	$ 0
Cost of Goods Sold	109,253	0	109,253	0
Gross Profit	214,987	0	214,987	0
Operating Expenses
General and Administrative	672,761	0	1,451,994	0
Professional Fees	310,383	4,854	946,070	4,854
Total Operating Expenses	983,144	4,854	2,398,064	4,854
Loss Before Other Income and (Expense)	(768,157)	(4,854)	(2,183,077)	(4,854)
Other Income and (Expense)
Gain on Debt Settlement	0	0	140,395	0
Gain (Loss) on Derivative	0	232,685	0	(21,972)
Unrealized Gain on Common Stock Payable	9,589,356	0	7,435,441	0
Gain on Issued Common Stock Payable	0	0	360,000	0
Interest Expense	(3,347)	(7,058)	(10,083)	(21,217)
Total Other Income and (Expense)	9,586,009	225,627	7,925,753	(43,189)
Income (Loss) Before Income Tax Expense	8,817,852	220,773	5,742,676	(48,043)
Income Tax Expense	0	0	0	0
Net Income (Loss) for the Period	$ 8,817,852	$ 220,773	$ 5,742,676	$ (48,043)
Weighted Average Number of Common Shares - Basic and Diluted (in shares)	50,425,551	48,491,485	49,131,485	48,491,485
Net Loss for the Period Per Common Shares - Basic and Diluted (in dollars per share)	$ 0.17	$ 0.00	$ 0.12	$ (0.00)